Incident use of tumor necrosis factor (TNF) inhibitors may be independently associated with an increased risk of progressive kidney function decline in patients with inflammatory bowel disease (IBD), according to findings from a retrospective cohort study published in JAMA Network Open.1
Despite effort and acknowledgement, new research shows kidney transplantation has not improved much in the last 2 decades for patients with end-stage kidney failure (EKSD).
In the US there has been a push to accept more transplant kidneys from hepatitis C viral (HCV) infected donors for hepatitis C negative recipients. A team, led by Miklos Z. Molnar, MD, PhD, Associate Professor of Medicine, University of Tennessee Health Science Center James D. Eason Transplant Institute, examined the association of HCV infected… Read More
